2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on HER2 Targeted Therapy in HER2+ MBC: Efficacy Comparison of Sequencing Newly Approved T-DM1 vs. Neratinib vs. Tucatinib With Existing Therapies
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Reshma L. Mahtani
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Reshma L. Mahtani
342 views
July 13, 2020
Comments 0
Login to view comments.
Click here to Login
Breast